LISATA THERAPEUTICS, INC. — Director's Dealing 2011

Apr 6, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2011-04-04

Reporting Person: HARRIS ALAN G (See Remarks)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-04-04	Stock Options (right to buy)	$1.74	A	150000	Acquired	2021-04-03	Common Stock, par value $0.001 per share (150000)	Direct

Footnotes

F1: On April 4, 2011, Dr. Harris was granted a stock option to purchase 150,000 shares of Common Stock under the Company's 2009 Equity Compensation Plan (the "2009 Plan"). This option is scheduled to vest as to 75,000 shares on each of October 4, 2011 and April 4, 2012. The option is subject to all the terms and conditions of the 2009 Plan.